SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $812,178 | +37.3% | 19,356 | +24.8% | 0.05% | +28.2% |
| Q4 2022 | $591,475 | -0.3% | 15,508 | +2.4% | 0.04% | 0.0% |
| Q3 2022 | $593,000 | +8.2% | 15,138 | -10.7% | 0.04% | +34.5% |
| Q2 2022 | $548,000 | +21.0% | 16,959 | +24.0% | 0.03% | +20.8% |
| Q1 2022 | $453,000 | -6.8% | 13,672 | +19.7% | 0.02% | -17.2% |
| Q4 2021 | $486,000 | -71.4% | 11,426 | -70.2% | 0.03% | -69.5% |
| Q3 2021 | $1,699,000 | +55.4% | 38,348 | +99.3% | 0.10% | +61.0% |
| Q2 2021 | $1,093,000 | +65.4% | 19,240 | +117.8% | 0.06% | +55.3% |
| Q1 2021 | $661,000 | -29.2% | 8,832 | -18.2% | 0.04% | -43.3% |
| Q4 2020 | $934,000 | -69.8% | 10,791 | -78.7% | 0.07% | -33.7% |
| Q3 2020 | $3,097,000 | +32.0% | 50,677 | -10.2% | 0.10% | +65.6% |
| Q2 2020 | $2,346,000 | +74.2% | 56,411 | +202.3% | 0.06% | +221.1% |
| Q4 2019 | $1,347,000 | +228.5% | 18,659 | +539.2% | 0.02% | +280.0% |
| Q3 2019 | $410,000 | +59.5% | 2,919 | +8.9% | 0.01% | -16.7% |
| Q4 2018 | $257,000 | -47.9% | 2,680 | -23.2% | 0.01% | -40.0% |
| Q3 2018 | $493,000 | +12.3% | 3,491 | +24.6% | 0.01% | -9.1% |
| Q2 2018 | $439,000 | -23.9% | 2,802 | -21.7% | 0.01% | -31.2% |
| Q1 2018 | $577,000 | – | 3,580 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |